Register For Our Mailing List

Register to receive our free weekly newsletter including editorials.

Home / 92

A lesson in bargaining, Medibank-style

Have you ever bargained? Has that special thrill of securing the once-in-a-lifetime bargain ever travelled up your spine? Have you, as the seller, laughed behind the aforesaid bargain hunter, savouring the thrill of their hallucination?

On the other hand, have you felt the pangs of pain piercing through your veins when you realised that the wonderful bargain you bought was available at half the cost at the fixed price store, and with full warranty to boot? Or as the seller you gave away a costlier piece?

Minister Mathias Cormann, who flogged Medibank Private’s Interesting Public Orgy (known as the IPO), used the bargaining method to great effect, but unlike the normal parties owning or acquiring the goods, he was neither. He acted as the agent for the taxpayers of Australia.

Even this is disputed by policyholders of Medibank. They claim that the Government never paid for its stake, and has sold their property for a cool 5 billion. Nice one, if you can get it.

Bizarre in the bazaar

So the good Senator rushes into the bazaar, where the wise, angelic or otherwise, tread warily. As those who have shopped in any Asian, South American or East European bargain basements would know, these are populated largely by touts, hangers-on, window-shoppers and price surveyors with a 1% incidence of shopper-crowd ratio.

He is promptly surrounded by merchant bankers, lead managers, brokers, accountants and advisers: ‘rent-seekers’ in trade parlance, who make their money regardless of whether the market stays up, down, sideways or comatose. In fact, whether the market remains at all. The true mark of a professional being making money, regardless.

With their professional help, how much stock to unload, what preferences and discounts to offer, in what time frames and when to hang up the shingles are all decided. Brokers are caught up in this endogenic frenzy, as they bid up their clients’ needs to secure firm allocations.

On the hallowed principle that ‘your money is safer with me than you’ (equivalent legal lingo: ‘possession is nine-tenths of the law’, the other 40% being consumed by counsel fees. Never count on them to count), the purchasers are asked to deposit more than they would eventually be liable for. The interest earnings would fund the Christmas party nicely, thank you.

The frenzy gets to the stage where the agent selling for the owner in the bargain basement plays, like a seasoned veteran, on the psychology of the bidders: will they sense losing out and bid for more? This is the moment you see in the souk when the shopkeeper thrashes his hands about in confected disgust, speaking in an unknown tongue. No translation needed: ‘raise your bid, or lose out’. In IPOs, the strange tongue takes the form of a product disclosure statement. Like Mark Twain’s classic, it is praised but never read.

During the actual sales period, the veiled threats continue. Did you hear that the issue is being several times oversubscribed? Is it likely that the issue will close earlier than the closing date? Did you know even firm allocations will have a haircut?

Like the clever shopkeeper in the souk, interested purchasers are streamed into multiple queues: pre-registered and general, stratified into policyholders, employees and the public. They may not know what either they or anyone else is doing in the queue, but it helps to behave as they did.

Subtle suggestions (or brazen shouts) about early bidders getting favoured treatment works like a treat. Everyone wants to be a favourite and rushes in, so no one is.

Come announcement time, our bargaining agent enlists, for a fee, those with the sharp pencil and the mind of an abacus to determine the basis of allocation. Like a treasurer with an unquenchable thirst for tax, he makes up a sliding scale, consisting of several tiers showing the allocation at each range: x shares up to A applied for, plus y% of any excess above A. Symptomatic of the crudity of the entire spectacle, y is usually a vulgar fraction. Are mathematicians into psychology?

People call up the brokers, the hotline and each other to understand what they got. Schadenfreude reigns: that the other mob fared worse than us is sweet music to the auditory receptacles.

On the appointed day for deferred settlement, our agent and the guy who will be left with the bathwater (a pity, really, about the baby) wear the smile of the cat that got the cream and shake up the polished bell vigorously. Something about the orgy must have polish to it, after all.

Not much left on the table

Would the heavens open up and financial nirvana be nigh? Zillions of eyes peer into the trading screen.

No record-breaking debut, this. A measly paper profit for the punter and even less for the ‘savvy’ institutions. As ennui sets in, the price dives below the insto-price, and with it goes the dream of powering up the portfolio performance. As the market settles back into its usual stupor, the hangers-on ready themselves for their next orgy.

As for the market price itself, it’s not quite settled. Will the disaffected policyholders sue for compensation? Will they vote with their wallets and walk, destroying value?

Who knows? As the philosopher Hume taught us in epistemology, inductive inferences are worth nothing, being circular. To prove them you must believe in them.

What about Mathias, our bargain agent? He finds that bargaining, like itching, can give a pleasant sensation but only as long as the scratching continues. He should look for more. Is this the first recorded case of agency risk infecting the agent, rather than the consumer as hitherto?

Bargain bazaars always imprint their lessons:

  • Investing for the long term and reacting to the first few days’ price is like planting tomatoes and uprooting them each day to see if all is well. Messy, and fruitless.
  • As in any IPO bargain, some (sellers) win; some (brokers) wine; the rest (index investors) whine. Win-win, it sure ain’t.

 

Ramani Venkatramani is an actuary and Principal of Ramani Consulting Pty Ltd. Between 1996 and 2011, he was a senior executive at ISC /APRA, supervising pension funds.

 

6 Comments
Ramani
December 18, 2014

OMG Tim, has that wily Mathias taken my hint and sold Medicare as well? I missed that...

Tim
December 16, 2014

Michael, Medicare was built with taxpayer funds by a government agency, therefore when it is sold the sale proceeds go back into the pool of money that is known as 'taxpayer funds' or consolidated revenue.

Call it what you will, but the sale proceeds will be used for govt expenditure on critical infrastructure Australia needs.

You don't own Medibank any more than you own the Harbour Bridge or Opera House.

Ramani
December 14, 2014

Michael

Very cute logic. Next time you are in Canberra, we may find you sound asleep at the Lodge, as you (presumably) own it already. I am sure Tony will accommodate you....

Michael
December 13, 2014

As a taxpayer, didn't we pay for Medibank already? I participated in the Telstra sale and my thoughts in the end were why am I paying for something I already own?

Capital Markets Guy
December 13, 2014

What I don't understand with the Medibank sale is why it makes sense to taxpayers: at a sale price of $5.5 billion, paying off debt would save about $165 million a year in interest payments, but the Government foregoes about $400 million a year in dividends, plus share price appreciation.

Richard Lambert
December 12, 2014

For a private purchaser how would ACCC view an offer to sell by a corporation

1 We will tell you the price in due course
2 you must pay a deposit which will be more than what you will end up paying
3 Because we will not tell you how many you will get but your payment will be held by us
4 We will tell you how many you bought and at what price
2 We will refund you any surplus above your deposit but without interest

 

Leave a Comment:

RELATED ARTICLES

What were the big stockmarket listings in record 2021?

Bounce back delivers super second-half for IPOs

The future has arrived in Australia

banner

Most viewed in recent weeks

Vale Graham Hand

It’s with heavy hearts that we announce Firstlinks’ co-founder and former Managing Editor, Graham Hand, has died aged 66. Graham was a legendary figure in the finance industry and here are three tributes to him.

Australian stocks will crush housing over the next decade, one year on

Last year, I wrote an article suggesting returns from ASX stocks would trample those from housing over the next decade. One year later, this is an update on how that forecast is going and what's changed since.

Taxpayers betrayed by Future Fund debacle

The Future Fund's original purpose was to meet the unfunded liabilities of Commonwealth defined benefit schemes. These liabilities have ballooned to an estimated $290 billion and taxpayers continue to be treated like fools.

Australia’s shameful super gap

ASFA provides a key guide for how much you will need to live on in retirement. Unfortunately it has many deficiencies, and the averages don't tell the full story of the growing gender superannuation gap.

Looking beyond banks for dividend income

The Big Four banks have had an extraordinary run and it’s left income investors with a conundrum: to stick with them even though they now offer relatively low dividend yields and limited growth prospects or to look elsewhere.

AFIC on its record discount, passive investing and pricey stocks

A triple headwind has seen Australia's biggest LIC swing to a 10% discount and scuppered its relative performance. Management was bullish in an interview with Firstlinks, but is the discount ever likely to close?

Latest Updates

Investment strategies

9 lessons from 2024

Key lessons include expensive stocks can always get more expensive, Bitcoin is our tulip mania, follow the smart money, the young are coming with pitchforks on housing, and the importance of staying invested.

Investment strategies

Time to announce the X-factor for 2024

What is the X-factor - the largely unexpected influence that wasn’t thought about when the year began but came from left field to have powerful effects on investment returns - for 2024? It's time to select the winner.

Shares

Australian shares struggle as 2020s reach halfway point

It’s halfway through the 2020s decade and time to get a scorecheck on the Australian stock market. The picture isn't pretty as Aussie shares are having a below-average decade so far, though history shows that all is not lost.

Shares

Is FOMO overruling investment basics?

Four years ago, we introduced our 'bubbles' chart to show how the market had become concentrated in one type of stock and one view of the future. This looks at what, if anything, has changed, and what it means for investors.

Shares

Is Medibank Private a bargain?

Regulatory tensions have weighed on Medibank's share price though it's unlikely that the government will step in and prop up private hospitals. This creates an opportunity to invest in Australia’s largest health insurer.

Shares

Negative correlations, positive allocations

A nascent theme today is that the inverse correlation between bonds and stocks has returned as inflation and economic growth moderate. This broadens the potential for risk-adjusted returns in multi-asset portfolios.

Retirement

The secret to a good retirement

An Australian anthropologist studying Japanese seniors has come to a counter-intuitive conclusion to what makes for a great retirement: she suggests the seeds may be found in how we approach our working years.

Sponsors

Alliances

© 2024 Morningstar, Inc. All rights reserved.

Disclaimer
The data, research and opinions provided here are for information purposes; are not an offer to buy or sell a security; and are not warranted to be correct, complete or accurate. Morningstar, its affiliates, and third-party content providers are not responsible for any investment decisions, damages or losses resulting from, or related to, the data and analyses or their use. To the extent any content is general advice, it has been prepared for clients of Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892), without reference to your financial objectives, situation or needs. For more information refer to our Financial Services Guide. You should consider the advice in light of these matters and if applicable, the relevant Product Disclosure Statement before making any decision to invest. Past performance does not necessarily indicate a financial product’s future performance. To obtain advice tailored to your situation, contact a professional financial adviser. Articles are current as at date of publication.
This website contains information and opinions provided by third parties. Inclusion of this information does not necessarily represent Morningstar’s positions, strategies or opinions and should not be considered an endorsement by Morningstar.